Xinyue Wang Selected Research

echinocystic acid

2/2021	Corrigendum to 'Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway' [Eur. J. Pharmacol., 861 (2019 oct 15), 172610].
10/2019	Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinyue Wang Research Topics

Disease

39	Neoplasms (Cancer) 06/2022 - 10/2009
7	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 09/2015
5	Stomach Neoplasms (Stomach Cancer) 06/2022 - 08/2018
5	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2019
4	Carcinogenesis 03/2021 - 04/2017
4	Brain Ischemia (Cerebral Ischemia) 02/2021 - 02/2019
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2015
4	Heart Failure 01/2021 - 04/2011
4	Inflammation (Inflammations) 01/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 08/2022 - 07/2014
3	Infections 06/2022 - 01/2011
3	Nasal Polyps (Nasal Polyp) 01/2022 - 01/2021
3	Disease Progression 01/2022 - 01/2021
3	Colitis 01/2022 - 01/2019
3	Adenocarcinoma of Lung 11/2021 - 01/2019
3	Reperfusion Injury 02/2021 - 02/2019
2	Crush Syndrome 02/2022 - 11/2020
2	Acute Kidney Injury (Acute Renal Failure) 02/2022 - 01/2022
2	Body Weight (Weight, Body) 02/2022 - 01/2021
2	Ischemic Stroke 01/2022 - 01/2021
2	HIV Infections (HIV Infection) 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 10/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2019
2	Lung Injury 01/2022 - 10/2021
2	Communicable Diseases (Infectious Diseases) 10/2021 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 04/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 01/2019
2	Disease Resistance 10/2019 - 10/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2018 - 10/2018
2	Carcinoma (Carcinomatosis) 08/2018 - 10/2016
2	Vomiting 01/2018 - 07/2014
2	Lymphatic Metastasis 04/2017 - 10/2016
2	Heart Diseases (Heart Disease) 03/2016 - 04/2011
2	Hypertrophy 12/2015 - 04/2011
1	Prostatic Neoplasms (Prostate Cancer) 10/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2022
1	Radiation Pneumonitis 08/2022
1	Pneumonia (Pneumonitis) 08/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2009
8	Pharmaceutical PreparationsIBA 08/2022 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
3	AntibodiesIBA 06/2022 - 11/2020
3	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 10/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2009
3	CytokinesIBA 01/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 01/2011
3	AntioxidantsIBA 01/2020 - 10/2019
3	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 05/2016
3	fullerenolIBA 01/2018 - 05/2015
2	Androgen Receptors (Androgen Receptor)IBA 10/2022 - 01/2020
2	ORALIT (ORS)IBA 08/2022 - 05/2016
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
2	Biological ProductsIBA 01/2022 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2021
2	Omalizumab (Xolair)FDA Link 01/2022 - 01/2021
2	Tamoxifen FDA LinkGeneric 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 04/2017
2	AntigensIBA 01/2022 - 11/2020
2	LipidsIBA 01/2022 - 05/2021
2	Estrogen ReceptorsIBA 01/2022 - 01/2021
2	VaccinesIBA 10/2021 - 01/2017
2	radixinIBA 03/2021 - 11/2020
2	moesinIBA 03/2021 - 11/2020
2	ezrinIBA 03/2021 - 11/2020
2	RNA (Ribonucleic Acid)IBA 03/2021 - 01/2021
2	echinocystic acidIBA 02/2021 - 10/2019
2	Plant ExtractsIBA 02/2021 - 10/2019
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021 - 12/2015
2	anlotinibIBA 01/2021 - 07/2018
2	Propofol (Diprivan)FDA LinkGeneric 01/2020 - 02/2019
2	AcidsIBA 01/2020 - 01/2020
2	Insulin-Like PeptidesIBA 10/2019 - 12/2015
2	Carcinoembryonic AntigenIBA 01/2019 - 05/2016
2	squamous cell carcinoma-related antigenIBA 01/2019 - 05/2016
2	Phosphopyruvate Hydratase (Enolase)IBA 01/2019 - 05/2016
2	Keratin-19 (Keratin 19)IBA 01/2019 - 05/2016
2	oxidized low density lipoproteinIBA 01/2019 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2019 - 06/2018
2	Steroid Receptors (Steroid Receptor)IBA 01/2018 - 01/2018
2	CalcineurinIBA 12/2015 - 04/2011
2	transcription factor NF-AT c3IBA 12/2015 - 04/2011
2	hydroxide ionIBA 12/2015 - 05/2015
1	NitratesIBA 06/2022
1	salinomycinIBA 06/2022
1	Docetaxel (Taxotere)FDA Link 06/2022
1	Biocompatible Materials (Biomaterials)IBA 06/2022
1	SuspensionsIBA 06/2022
1	SolutionsIBA 06/2022
1	poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol)IBA 06/2022
1	GelatinasesIBA 06/2022

Therapy/Procedure

14	Therapeutics 06/2022 - 09/2015
7	Drug Therapy (Chemotherapy) 06/2022 - 07/2014
6	Immunotherapy 08/2022 - 01/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 07/2011
2	Adjuvant Chemotherapy 01/2022 - 01/2020
2	Fecal Microbiota Transplantation 01/2022 - 01/2019
2	Radiotherapy 01/2021 - 11/2016
2	Percutaneous Coronary Intervention 01/2019 - 01/2017